Paul Robert Owen Whittamore
Paul Robert Owen Whittamore, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20090124682 | Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity - A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here—please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. | 05-14-2009 |
20090221663 | PYRAZOLE DERIVATIVES AS 11-BETA-HSD1 INHIBITORS - A compound of Formula (I): | 09-03-2009 |
20100022589 | PYRIDINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE FOR INHIBITING 11-BETA-HYDROXYSTEROID DEHYDROGENASE - Compounds of formula (I): | 01-28-2010 |
20110065706 | Therapeutic Agents 812 - A compound of formula I | 03-17-2011 |
20110092526 | Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826 - A compound of formula (I): | 04-21-2011 |
20110224273 | Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors - A compound of formula (I): | 09-15-2011 |
Paul Robert Owen Whittamore, London Greater London GB
Patent application number | Description | Published |
---|---|---|
20110060022 | 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic Acid - 465 - 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid and pharmaceutically-acceptable salts thereof and a particular crystalline form of the Agent (Form 1); their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described. | 03-10-2011 |
Paul Robert Owen Whittamore, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20080269288 | CHEMICAL COMPOUNDS - Compounds of formula (I): | 10-30-2008 |
20090264401 | SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281 - A compound of formula (I): | 10-22-2009 |
20090306075 | CHEMICAL COMPOUNDS - Compounds of formula (I): | 12-10-2009 |
20090312372 | CHEMICAL COMPOUNDS - Compounds of formula (I): | 12-17-2009 |
20100137397 | Chemical Compounds - A compound of the formula (1) or a pharmaceutically-acceptable salt: possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity such as 2 diabetes. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. | 06-03-2010 |